Tanuja Chitnis, MD

Associate neurologist, Brigham and Women's Hospital; professor of neurology, Harvard Medical School


Defining Treatment Failure in Pediatric MS

April 27, 2021

Lauren B. Krupp, MD considers how treatment failure in pediatric multiple sclerosis may be defined as disease relapse, new or enlarging legions, inability to tolerate treatment, or lack of adherence.

Disease-Modifying Therapy in Relapsing-Remitting MS

April 20, 2021

Leaders in neurology provide insight into first-line disease-modifying therapies for relapsing-remitting multiple sclerosis, such as interferon or glatiramer acetate, and glucocorticoids for acute events.